Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis

NCT01547091 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)
DRUG: Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)
BIOLOGICAL: UC-MSC+DMARDS

Sponsor

Alliancells Bioscience Corporation Limited